EZR and metastatic neoplasm: Surprisingly, there was no significant correlation between FAK expression levels, Ezrin expression, or phosphorylation of FAK and clinicopathological characteristics, such as overall survival, response to chemotherapy, first relapse, or presence of metastatic disease at the time of diagnosis.